Navigation Links
Kaiser Foundation Health Plan Earnings Support Investments in Member and Community Health
Date:11/7/2007

lth record, My health manager. The largest civilian electronic health record project in the United States, KP HealthConnect now supports 6.5 million of its 8.7 million members with ambulatory/outpatient electronic medical records. Currently, the system enables more than 275,000 secure online messages a month sent between Kaiser Permanente patients, doctors and clinicians.

"We are investing in KP HealthConnect because we realize that the information needs of caregivers are changing at a phenomenal pace," said KFHP/H Chairman and Chief Executive Officer George Halvorson. "KP HeathConnect will not only give us the best healthcare database in the world, it also will give us the capacity to collect extensive data to meet our caregivers' information needs so that they can serve patients better."

As a not-for-profit organization, KFHP/H's revenues fund numerous community benefit programs, which provide direct health care coverage for uninsured families, community-based health partnerships and research and collaboration with community health organizations. One such example is the organization's long-standing support for the safety net -- institutions that provide care to the underserved and uninsured in our communities. Over the past year, KFHP/H has been instrumental in providing low-income, uninsured patients suffering from diabetes with the proper medications designed to prevent related heart attacks and strokes. In 2006, the organization spent $807 million on community benefits.

As he has emphasized in the past, Halvorson added, "The people of Kaiser Permanente are here to make lives better. Our integrated care delivery system can achieve success through the commitment of our physicians, nurses, caregivers, and all of our employees who work together to serve our customers, members and communities."

Except for historical information contained herein, the matters discussed in this media release are forward-looking statements that involve risks and
'/>"/>

SOURCE Kaiser Foundation Health Plan Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Webcast Alert: Kaiser Permanente Residency Program Open House
2. Kaiser Permanente Achieves Climate Action Leader Status
3. Kaiser Permanente study: Alcohol amount, not type -- wine, beer, liquor -- triggers breast cancer
4. Kaiser Permanente Study Shows Alcohol Consumption - No Matter Beverage Type - Linked to Breast Cancer Risk
5. Kaiser Permanente Study Shows One in Seven Women are Depressed Before, During, or After Pregnancy
6. Kaiser Permanente Named Green Electronics Champion by EPA, Green Electronics Council
7. WellBound Teams With Kaiser Permanente to Open New Self-Care Dialysis Center in Sacramento, CA
8. Kaiser Permanente Joins With Top Health Care Groups to Create Healthier Hospital Environments
9. Kaiser Permanente study shows electronic medical records and outreach improve osteoporosis care
10. Kaiser Permanente CEO Receives Diversity Leadership Award
11. Kaiser Permanente and Golden State Warriors Team Up to Fight Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...K, Nov. 21 The general membership ...induct three new individuals at their Annual,Awar...re hotel in New York. A,Lifetime Achievement Awar...into the Medical Advertising Hall of Fame are: , ...r with an account position,at Sudler & Hennes...
(Date:11/21/2008)...ound 2 popular drugs do not cause genetic damage t... 21 (HealthDay News) -- Two popular medications fo...r (ADHD) do not cause genetic damage linked to an ...says. , The study, done by researchers at Duke ...tes of Health, counters a previous one that report...
(Date:11/21/2008)... Nov. 21 In a statewide survey, 33...Institute for Surgery at Presbyterian Hospital of ... annual listing of " Super Doctors ." , , E...ith Key Professional Media, Inc. to survey more th...f Texas to ask, "If you needed medical care, which...
(Date:11/21/2008)... Ind., Nov. 21 Symmetry ... provider of products to the global orthopedic dev...today that Brian S. Moore, President and Chief Exe...ident and Chief Financial Officer, are scheduled t...Care Conference at The New York Palace Hotel on We...
Breaking Medicine News(10 mins):Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2
...he Food and Drug Administration cracked down on In...d lip balm, declaring them illegal and ordering th...ops in particular pose a risk to children because ...e quantity of nicotine could be potentially danger...
...ccording to a research, women who live at high alt...heir conclusions after finding lower concentration... health and youthfulness, in women living in the m...ers looked at a control group of 160 women of simi...
...ccording to a new study taking cholesterol-lowerin... of peripheral neuropathy. Previous research has s...lesterol levels. However, researchers in Texas now...k of peripheral neuropathy, a condition marked by ...
...ccording to a new review of the medical proof, the... of venous leg ulcers. Venous leg ulcers are cause...ong people aged 60 or over. Standard treatment is ...p to a third of people still have unhealed ulcers ...
Other Medicine News:Health News:High Altitude ‘Speeds up ageing process 2
(Date:11/19/2008)... report basic findings on critical enzyme,s regula...reat an array of disorders , , MEMPHIS, Ten... at St. Jude Children,s Research Hospital have gai...y,s enzyme workhorses called calpains. , , ...unction in many cellular processes, including the ...
(Date:11/19/2008)...19 Isogen, a contract development ...g, today announced the first,phase launch of its ...to,specifically address the process, facility and...2 billion highly-niched, low-volume clinical and,...ent. , Companies can invest over $100 milli...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX... and drug development Company,and Sosei Group Co...ading,international biopharmaceutical company, to...rther pivotal pre-clinical efficacy data for NSL-0...l therapy for neuropathic pain and has,successful...
(Date:11/18/2008)...18 Arlington Medical Resources (AM... the pharmaceutical and diagnostic,imaging indust... Privigen was,sold in the U.S. during the third q...ntravenous immune globulin (IVIG) and was launched...created from the blood plasma of thousands,of don...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 250 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 150 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 250 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 350 Million Pound Challenge Teams Up With Churches to Spread the Gospel of Healthy Living 10345 4SoluLinK Introduces ChromaLink 28TM 29 Biotin Labeling Kit to Biotinylate and Measure With One Reagent 2822 1SoluLinK Introduces ChromaLink 28TM 29 Biotin Labeling Kit to Biotinylate and Measure With One Reagent 2822 2Prison study to investigate link between diet and behavior 2042 1Prison study to investigate link between diet and behavior 2042 2Carbon monoxide may cause long lasting heart damage 2038 1Carbon monoxide may cause long lasting heart damage 2038 2
...mboEmbolism (VTE) is Reduced by a,Significant 43% ...xane(R) / Lovenox(R), BRIDGEWATER, N.J., April 20,...ounced the publication of the PREVAIL (Prevention,...parin) trial in,the April 21st issue of The Lancet...administration of Clexane(R) / Lovenox(R),(enoxapa...
... 23, 2007 - Ceragenix Pharmaceuticals,Inc. (OTCBB...ectious disease and dermatology, today announced t...ompany,s antimicrobial,compounds: CSA-8 and CSA-13...rnal of Antimicrobial Agents and Chemotherapy, a,p...ety of,Microbiology, dedicated to advances in the ...
Other Medicine Technology:The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 2The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 3The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 4The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 5The Lancet Publishes PREVAIL Study Results Showing Lovenox,Superiority Over Unfractionated Heparin for Reducing the Risk of,Venous ThromboEmbolism in Patients With Acute Ischemic Stroke 6Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4
The LH 755 simplifies and automates high-volume hematology testing by integrating expert automation and advanced technologies into one workcell. It delivers reliable, accurate results every time. Plu
Kinetic and endpoint methods for the quantitative determination of creatinine in serum.
For the quantitative determination of creatine kinase-MB in serum. Kinetic Reaction measured at 340 nm. Linearity: 700 IU/L at 37C.
Intended for the quantitative determination of magnesium in serum. Wavelength: 340 nm. Linearity: 9.7 mg/dL (4 mmol/L). Two vials, dry powder reagents.
Medicine Products: